Biotechnology

Techseriesinsight > Blog > News > Biotechnology

December 19, 2024
PRNewswire
Biotechnology

Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced they have entered into a license agreement allowing...

December 18, 2024
PRNewswire
Biotechnology

Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.

Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has acquired the VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.. The agreement also includes...

December 18, 2024
PRNewswire
Biotechnology

Novo Nordisk Foundation grants €134.1 million to establish the Biotechnology Research Institute for the Green Transition (BRIGHT) in Denmark

Our daily lives are full of products and processes based on fossil materials, or created using fossil energy sources such as oil and gas. To make significant progress in...

December 18, 2024
Business Wire
Biotechnology

Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, announced today latest data updates confirming...

December 17, 2024
Business Wire
Biotechnology

Soilytix Pioneers Breakthrough in Soil Microbiome Research for Global Crop Yield Predictions

Soilytix GmbH, a leading innovator in soil microbiome analytics, announces a groundbreaking study recently published in Science of the Total Environment. The research, titled “Local Microbial Yield-Associating Signatures Largely Extend...

December 16, 2024
PRNewswire
Biotechnology

Promise Bio Emerges from Stealth with $8.3M Seed Investment to Transform Precision Medicine for Immune-Mediated Diseases

Promise Bio, a startup transforming immune-mediated disease treatment with advanced precision medicine solutions, today announced its emergence from stealth with an $8.3 million seed investment. This funding will accelerate the development...

December 16, 2024
Business Wire
Biotechnology

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that Adcendo ApS (“Adcendo”), a biotech company focused...

December 16, 2024
PRNewswire
Biotechnology

Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers

Nona Biosciences, a global biotechnology company providing a total solution from “Idea to IND” (I to ITM), today announced a research collaboration and license agreement to discover next-generation T-cell engagers (“TCEs”)...

December 6, 2024
PRNewswire
Biotechnology

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on December 2, 2024, the Compensation Committee of IDEAYA’s...

December 6, 2024
PRNewswire
Biotechnology

Another star technology platform of the Sanyou AI-STAL family

With the announcement of the 2024 Nobel Prize in Physiology or Medicine, microRNA has once again become the focus of global attention. In the past 20 years, three Nobel Prizes...